Article info

Download PDFPDF
Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy

Authors

  1. Address correspondence and reprint requests to Lubomir Bodnar, PhD, MD, Department of Oncology, Military Institute of Medicine, 04-141 Warsaw, 128 Szaserow Str, Poland. E-mail: lubo{at}esculap.p.

Citation

Gąsowska-Bodnar A, Bodnar L, Dąbek A, et al
Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy

Publication history

  • Received November 17, 2013
  • Accepted January 14, 2014
  • First published May 1, 2014.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.